Advanced BioScience Laboratories,Inc. – Retrovirus Research Reagents＆Kits（HIV/SIV/HTLV）
Advanced BioScience Laboratories,Inc. (located Maryland, USA) is an expert in retrovirus related research with a focus on HIV. Through working with US national institutions such as the NIH and universities, ABL aims to contribute to the study, prevention, and product development in the field of infectious diseases starting with AIDS. ABL also provide custom animal model as a service, with consulting and testing services for the client’s chosen development material and animal models.
ELISA Kits
| Cat. No. | Product Name | Size |
|---|---|---|
| 5421 | HIV-1 p24 Antigen Capture Assay | 96-well plate |
| 5429 | HIV-1 gp120 Antigen Capture Assay | 96-well plate |
| 5436 | SIV p27 Antigen Capture Assay (backordered until March 18th) | 96-well plate |
| 5447 | Bulk HIV-1 p24 10 plates/kit | 10 plates (96-well plate) |
| 5450 | Bulk SIV p27 10 plates/kit (backordered until March 18th) | 10 plates (96-well plate) |
Viral Products
| Cat. No. | Product Name | Size |
|---|---|---|
| 5424 | HIV-1 451 gp120 (Native) | 100 μg |
| 5425 | HIV-1 IIIB p24 | 100 μg |
| 5426 | HIV-1 IIIB gp160 (Native) | 100 μg |
| 5427 | HIV-1 451 gp160 (Native) | 100 μg |
Antibodies & Antiserum
| Cat. No. | Product Name | Size |
|---|---|---|
| 4300 | Anti-HTLV-I p21E Env | 100 μg |
| 4301 | Anti-HIV-1 gp120 Env (Broadly Reactive) | 100 μg |
| 4302 | Anti-HIV-1 gp120 Env (C2 Domain; Type M and O) | 100 μg |
| 4303 | Anti-HIV-1 gp120 Env (Type O) | 100 μg |
| 4304 | Anti-HIV-1 gp41 Env (Type O) | 100 μg |
| 4305 | Anti-HIV-1 Tat | 100 μg |
| 4310 | Anti-HTLV-I p24 Gag | 100 μg |
| 4311 | Anti-HIV-1 gp120 Env (Conformational) | 100 μg |
| 4312 | Anti-HIV-1 gp41 Env | 100 μg |
| 4313 | Anti-HIV-1 p24 Gag | 100 μg |
| 4314 | Anti-HIV-1 p17 Gag | 100 μg |
| 4315 | Anti-HIV-1 p66/51 (RT) | 100 μg |
| 4317 | Anti-HIV-1 gp120 Env (aa 307-320) | 100 μg |
| 4322 | Anti-SIV gp32 Env (weakly neutralizing) | 100 μg |
| 4323 | Anti-SIV p27 Gag | 100 μg |
| 4324 | Anti-SIV p27 Gag (cross-reacts with HIV-1/2) | 100 μg |
| 4325 | Anti-SIV p17 Gag | 100 μg |
| 4326 | Anti-SIV gp120 Env | 100 μg |
| 4327 | Anti-SIV gp120 Env (neutralizing) | 100 μg |
| 5407 | Anti-HIV-1 p17 Gag | 1mL |
| 5408 | Anti-HIV-1 gp120 Env (Clade E, 93TH976) | 1mL |
| 5411 | Anti-HIV-1 gp120 Env (Clade C, 96ZM651) | 1mL |
| 5412 | Anti-HIV-1 p24 Gag | 1mL |
| 5413 | Anti-SIV gp120 Env (Mac251) | 1mL |
| 5414 | Anti-HIV-1 gp120 Env (Clade B, IIIB) | 1mL |
| 5415 | Anti-HIV-1 Tat | 1mL |
| 5416 | Anti-HIV-1 Nef | 1mL |
| 5418 | Anti-HTLV-I p24 Gag | 1mL |
| 5419 | Anti-HIV-1 gp120 Env (Clade A, 92UG037) | 1mL |
| 5420 | Anti-HIV-1 gp120 Env (Clade B, Ba-L) | 1mL |
| 5422 | Anti-HIV-1 gp120 Env (Clade D, 57140) | 1mL |
Please contact us for any inquiries, questions, or information requests.
Tokyo Future Style, Inc.
info@tokyofuturestyle.com
TEL：029-851-9222 FAX：029-851-9220
